RETHINK PHARMA AS
Operating
Salg, service, distribusjon og utvikling av medisinsk utstyr og
farmasiprodukter, samt det som naturlig står i forbindelse med dette.
Salg, service, distribusjon og utvikling av medisinsk utstyr og
farmasiprodukter.
Keywords
pharmaceuticalshospital equipmentorthopedic articles
Organization
- CEO
- GR
Gøran Røstad1975
- Chairman of the board
- GR
Gøran Røstad1975
- Years since formation
- 5 years
- since Mar 23, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30
- 1 share class
- Total number of shareholders
- 2
- companies
Financials
- Annual total result 2025
- -430,771
- NOK
- Total equity 2025
- -705,700
- NOK
Last update: Sep 1, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
GR 1975 | Managing Director/CEO | 50 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
GR 1975 | Chairman | 50 % indirectly |
| Board Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
GR 1975 | Managing Director/CEO, Chairman | 50 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 15 | 50 % | |
| Ordinary shares | 15 | 50 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 495 | 0 | 9,718 |
Annual Total Result | -430,771 | -1,171 | -130,093 | -46,746 |
Total assets | 9,442 | 431,386 | 517,687 | 4,353 |
Total liabilities | 715,142 | 706,315 | 664,527 | 21,099 |
Total equity | -705,700 | -274,928 | -146,840 | -16,746 |
P&L
| Year | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 495 | 0 | 9,718 |
Total operating costs | 430,321 | 1,615 | 130,665 | 56,526 |
Operating result | -430,321 | -1,120 | -130,665 | -46,808 |
Financial income/costs | -450 | -51 | 571 | 62 |
Profit before tax | -430,771 | -1,171 | -130,093 | -46,746 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -430,771 | -1,171 | -130,093 | -46,746 |
Balance overview
| Year | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 9,442 | 431,386 | 517,687 | 4,353 |
Total assets | 9,442 | 431,386 | 517,687 | 4,353 |
Short term debt | 566,202 | 557,375 | 664,527 | 21,099 |
Long term debt | 148,940 | 148,940 | 0 | 0 |
Total liabilities | 715,142 | 706,315 | 664,527 | 21,099 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -735,700 | -304,928 | -176,840 | -46,746 |
Total equity | -705,700 | -274,928 | -146,840 | -16,746 |
Total equity and liabilities | 9,442 | 431,387 | 517,687 | 4,353 |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods